A potent drug candidature of Cu(II) pyrazino[2,3‐f][1,10]phenanthroline complexes with bioactive ligands: synthesis, crystal structures, biomolecular interactions, radical scavenging and cytotoxicities

dc.contributor.authorİnci, Duygu
dc.contributor.authorZorlu, Yunus
dc.contributor.buuauthorAydın, Rahmiye
dc.contributor.buuauthorVatan, Özgür
dc.contributor.departmentBursa Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Kimya Bölümü.tr_TR
dc.contributor.departmentBursa Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Biyoloji Bölümü.tr_TR
dc.contributor.orcid0000-0002-7687-3284
dc.contributor.orcid0000-0003-4944-0181
dc.contributor.researcheridO-7508-2015tr_TR
dc.contributor.researcheridAAH-8936-2021tr_TR
dc.contributor.scopusid56261495600tr_TR
dc.contributor.scopusid16235098100tr_TR
dc.date.accessioned2024-01-17T06:15:24Z
dc.date.available2024-01-17T06:15:24Z
dc.date.issued2020-08-01
dc.description.abstractA novel ternary copper(II) complexes, - [Cu(py-phen)(asn)(NO3)(H2O)] (1) and [Cu(py-phen)(trp)(H2O)]NO3(2)- (py-phen: pyrazino[2,3-f][1,10]phenanthroline, asn: asparagine, trp: tryptophan), have been synthesized and characterized by CHN analysis, ESI-MS, FTIR and single-crystal X-ray diffraction techniques. Interaction of the complexes1and2with CT-DNA has been investigated by absorption spectral titration, EB and Hoechst 33258 displacement assay. The interaction between the complexes1and2and BSA was investigated by electronic absorption and fluorescence spectroscopy methods. The experimental outcomes indicate that the fluorescence quenching mechanism between the complexes1and2and BSA is a static quenching process. The Stern-Volmer constants, binding constants, binding sites and the corresponding thermodynamic parameters (Delta G, Delta H, Delta S) of BSA + complex systems were determined at different temperatures. The binding distance between the complexes1and2and BSA was calculated according to FRET. The effect of the complexes1and2on the conformation of BSA was also examined using synchronous, two dimensional (2D) and three dimensional (3D) fluorescence spectroscopy. Radical scavenging activity of the complex was determined in terms of EC50, using the DPPH and H(2)O(2)method. The anticancer activities of the complexes1and2were investigated using an XTT assay against three cancer cell lines (MCF-7, Caco-2 and A549) and non-tumor cell line (BEAS-2B). A potent drug candidature of two new copper(II) complexes, - [Cu(py-phen)(asn)(NO3)(H2O)] (1) and [Cu(py-phen)(trp)(H2O)]NO3(2)- (py-phen: pyrazino[2,3-f][1,10]phenanthroline, asn: asparagine, trp: tryptophan), have been synthesized and characterized by CHN analysis, FTIR, ESI-MS and single-crystal X-ray diffraction techniques. The complexes have been tested for theirin vitrobiomolecular interactions by the spectroscopic methods. Furthermore, radical scavenging and anticancer activities of the complexes was also investigated.en_US
dc.identifier.citationİnci, D. vd. (2021). "A potent drug candidature of Cu(II) pyrazino[2,3‐f][1,10]phenanthroline complexes with bioactive ligands: Synthesis, crystal structures, biomolecular interactions, radical scavenging and cytotoxicities". Journal of Biomolecular Structure and Dynamics, 39(18), 7194-7212.en_US
dc.identifier.doihttps://doi.org/10.1080/07391102.2020.1808070
dc.identifier.eissn1538-0254
dc.identifier.endpage7212
dc.identifier.issn0739-1102
dc.identifier.issue18tr_TR
dc.identifier.pubmed32811370tr_TR
dc.identifier.scopus2-s2.0-85089592340tr_TR
dc.identifier.startpage7194
dc.identifier.urihttps://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1808070
dc.identifier.urihttps://hdl.handle.net/11452/39080
dc.identifier.volume39tr_TR
dc.identifier.wos000560478200001tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherTaylor and Francisen_US
dc.relation.bap(BİYGP-2018/1)
dc.relation.collaborationYurt içitr_TR
dc.relation.journalJournal of Biomolecular Structure and Dynamicsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBiochemistry & molecular biologyen_US
dc.subjectBiophysicsen_US
dc.subjectAmino acidsen_US
dc.subjectAnticancer activityen_US
dc.subjectBiomolecular interactionsen_US
dc.subjectCu(II)en_US
dc.subjectPyrazino[2,3‐f][1,10]phenanthrolineen_US
dc.subjectRadical scavenging activityen_US
dc.subjectBovine serum-albuminen_US
dc.subjectDNA-bindingen_US
dc.subjectCopper(II) complexen_US
dc.subjectEthidium-bromideen_US
dc.subjectMetal-complexesen_US
dc.subjectRuthenium(II)en_US
dc.subjectFluorescenceen_US
dc.subjectAntioxidanten_US
dc.subjectDNA/BSAen_US
dc.subjectOxygenen_US
dc.subject.emtreeAntineoplastic agenten_US
dc.subject.emtreeAntineoplastic agenten_US
dc.subject.emtreeBovine serum albuminen_US
dc.subject.emtreeUnclassified drugen_US
dc.subject.emtreeCopper pyrazino[2,3 f][1,10]phenanthroline complexen_US
dc.subject.emtreeCisplatinen_US
dc.subject.emtreeCoordination compounden_US
dc.subject.emtreeCopperen_US
dc.subject.emtreeDrugen_US
dc.subject.emtreeHydrogen peroxideen_US
dc.subject.emtreeLiganden_US
dc.subject.emtreePhenanthroline derivativeen_US
dc.subject.emtreeA-549 cell lineen_US
dc.subject.emtreeMolecular interactionen_US
dc.subject.emtreeIC50en_US
dc.subject.emtreeMCF-7 cell lineen_US
dc.subject.emtreeHydrogen peroxide scavenging assayen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHuman cellen_US
dc.subject.emtreeFree radical scavenging assayen_US
dc.subject.emtreeFluorescence resonance energy transferen_US
dc.subject.emtreeEC50en_US
dc.subject.emtreeElectrospray mass spectrometryen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeSpectrofluorometryen_US
dc.subject.emtreeXTT assayen_US
dc.subject.emtreeX ray diffractionen_US
dc.subject.emtreeThermodynamicsen_US
dc.subject.emtreeDrug conformationen_US
dc.subject.emtreeDrug effecten_US
dc.subject.emtreeDPPH radical scavenging assayen_US
dc.subject.emtreeCytotoxicityen_US
dc.subject.emtreeCrystal structureen_US
dc.subject.emtreeDrug efficacyen_US
dc.subject.emtreeBEAS-2B cell lineen_US
dc.subject.emtreeDrug mechanismen_US
dc.subject.emtreeDrug responseen_US
dc.subject.emtreeDrug structureen_US
dc.subject.emtreeDrug synthesisen_US
dc.subject.emtreeBinding siteen_US
dc.subject.emtreeCaco-2 cell lineen_US
dc.subject.emtreeClinical effectivenessen_US
dc.subject.emtreeComplex formationen_US
dc.subject.emtreeControlled studyen_US
dc.subject.meshAntineoplastic agentsen_US
dc.subject.meshCaco-2 cellsen_US
dc.subject.meshCoordination complexesen_US
dc.subject.meshCopperen_US
dc.subject.meshHumansen_US
dc.subject.meshHydrogen peroxideen_US
dc.subject.meshLigandsen_US
dc.subject.meshPharmaceutical preparationsen_US
dc.subject.meshPhenanthrolinesen_US
dc.subject.meshSerum albuminen_US
dc.subject.meshBovineen_US
dc.subject.scopusComplex; Viscometry; Schiff Basesen_US
dc.subject.wosBiochemistry & molecular biologyen_US
dc.subject.wosBiophysicsen_US
dc.titleA potent drug candidature of Cu(II) pyrazino[2,3‐f][1,10]phenanthroline complexes with bioactive ligands: synthesis, crystal structures, biomolecular interactions, radical scavenging and cytotoxicitiesen_US
dc.typeArticleen_US
dc.wos.quartileQ2 (Biochemistry & molecular biology)en_US
dc.wos.quartileQ1 (Biophysics)en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections